FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

MAPP on NDA/BLA Financial Disclosure

CDER issues a MAPP on how Office of New Drugs reviewers are to handle the review and management of financial disclosure submitted in NDAs, BLAs, and t...

Medical Devices

K2M Gains Clearance for Expandable Interbody System

FDA clears a K2M Group Holdings 510(k) for its Mojave PL 3D Expandable Interbody System, a 3D-printed expandable posterior-lumbar interbody system.

Human Drugs

Generic Drug Bioequivalence Study MAPP

CDER publishes a MAPP on Office of Generic Drugs review of borquivalence studies with clinical endpoints.

Medical Devices

Merit Gains Expanded Use for Prostate Surgery

Merit Medical Systems gains de novo clearance from FDA to expand the indication for its Embosphere Microspheres to now include prostatic artery emboli...

Medical Devices

FDA Approves VNS Therapy Systems for Expanded MRI Scans

FDA approves LivaNovas VNS Therapy systems for expanded MRI labeling, allowing patients to visit any MRI center in the U.S. and have access to more th...

Federal Register

Comments Sought on FDA Fellowship Applications

Federal Register notice: FDA seeks comments on an information collection extension for Application for Participation in FDA Fellowship Programs.

Support for FDA Patient Engagement Plans

Stakeholders support FDAs plan to create an Office of Patient Affairs and ask for clarifications and changes in its possible structure and operations....

Gorsuch Likely to Maintain Preemption Jurisprudence: Lawyers

Two Shook, Hardy & Bacon attorneys say that new Supreme Court justice Neil Gorsuch is likely to favor textualism in the courts ongoing debate over fed...

Human Drugs

FDA Public Meeting on Generic Drug Barriers

FDA commissioner Scott Gottlieb announces a public meeting to hear input on ways that the agency can eliminate problems in approval of generic drugs.

Human Drugs

Compounded Drug Access Bill Introduced

Rep. Morgan Griffith introduces legislation to preserve patient access to compounded drugs.